QS Investors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $201K | Sell |
2,058
-300
| -13% | -$29.3K | ﹤0.01% | 1066 |
|
2021
Q1 | $230K | Hold |
2,358
| – | – | ﹤0.01% | 1069 |
|
2020
Q4 | $226K | Buy |
2,358
+257
| +12% | +$24.6K | ﹤0.01% | 1080 |
|
2020
Q3 | $203K | Hold |
2,101
| – | – | ﹤0.01% | 1071 |
|
2020
Q2 | $257K | Sell |
2,101
-425
| -17% | -$52K | ﹤0.01% | 1077 |
|
2020
Q1 | $219K | Buy |
2,526
+185
| +8% | +$16K | ﹤0.01% | 1040 |
|
2019
Q4 | $254K | Sell |
2,341
-240
| -9% | -$26K | ﹤0.01% | 1135 |
|
2019
Q3 | $233K | Buy |
2,581
+240
| +10% | +$21.7K | ﹤0.01% | 1167 |
|
2019
Q2 | $198K | Hold |
2,341
| – | – | ﹤0.01% | 1222 |
|
2019
Q1 | $207K | Sell |
2,341
-9
| -0.4% | -$796 | ﹤0.01% | 1210 |
|
2018
Q4 | $168K | Hold |
2,350
| – | – | ﹤0.01% | 1183 |
|
2018
Q3 | $289K | Hold |
2,350
| – | – | ﹤0.01% | 1102 |
|
2018
Q2 | $231K | Hold |
2,350
| – | – | ﹤0.01% | 1165 |
|
2018
Q1 | $195K | Hold |
2,350
| – | – | ﹤0.01% | 1184 |
|
2017
Q4 | $182K | Buy |
2,350
+341
| +17% | +$26.4K | ﹤0.01% | 1244 |
|
2017
Q3 | $123K | Hold |
2,009
| – | – | ﹤0.01% | 1377 |
|
2017
Q2 | $92K | Hold |
2,009
| – | – | ﹤0.01% | 1399 |
|
2017
Q1 | $87K | Buy |
2,009
+2,000
| +22,222% | +$86.6K | ﹤0.01% | 1412 |
|
2016
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 1674 |
|
2016
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1664 |
|
2016
Q2 | $1K | Sell |
9
-136,502
| -100% | -$15.2M | ﹤0.01% | 1707 |
|
2016
Q1 | $5.4M | Hold |
136,511
| – | – | 0.05% | 358 |
|
2015
Q4 | $7.72M | Buy |
136,511
+10,359
| +8% | +$586K | 0.07% | 244 |
|
2015
Q3 | $5.02M | Sell |
126,152
-200
| -0.2% | -$7.96K | 0.05% | 357 |
|
2015
Q2 | $6.04M | Hold |
126,352
| – | – | 0.07% | 321 |
|
2015
Q1 | $5.02M | Hold |
126,352
| – | – | 0.06% | 376 |
|
2014
Q4 | $2.82M | Buy |
+126,352
| New | +$2.82M | 0.03% | 510 |
|